• To global navigation
  • To contents

Mitsubishi Tanabe Pharma

  • HOME
  • JAPANESE TOP
  • Site Map
  • Contact Us

Mitsubishi Chemical Holdings Group

Print

  • Corporate Information
    • Message From The Management
    • Philosophy and Vision,Corporate Behavior Charter
    • Quality Policy
    • Compliance
    • Medium-Term Management Plan
    • Corporate Data
    • Management
    • Organization Chart
    • Network
    • Group Companies
    • Brand Mark
    • Corporate History
    • CSR Report
  • Research&Development
    • Developing Innovative New Drugs
    • R&D Pipeline
    • Clinical Trial Information
    • Research Reagent
  • Investor Relations
    • IR Top
    • Shareholder's Meeting
    • Financial Results
    • Financial Data
    • IR Meeting
    • Annual Report
    • IR Library
    • FAQ
    • IR Calendar
    • IR Inquiries
    • Cautionary Note
  • News Release
    • News Release
    • Topics

HOME>News Release>Mitsubishi Pharma Corporation

News Release : Mitsubishi Pharma Corporation 2003

  • Mitsubishi Tanabe Pharma
  • Former TANABE SEIYAKU
  • Former Mitsubishi Pharma
  • 2007
  • 2006
  • 2005
  • 2004
  • 2003
  • 2002
  • 2001

2003

12/17
Outcome of Takeover Bid for Mitsubishi Pharma Corporation by Mitsubishi Chemical Corporation
11/12
Announcement of agreement to takeover bid PDF
11/5
Outline of Mid-Term Corporate Action Plan (FY2004-2006) PDF
10/15
Notice of revised business result forecast (consolidated and non-consolidated) PDF
7/22
Agreement concluded on transfer of OTC business
5/28
Transfer of Bulk Drug Operations
5/8
Mitsubishi Pharma Submits a Marketing Authorization Application in Europe for Argatroban and Is to Establish a Local Corporation in Germany
4/10
Notice of revised business result forecast (consolidated and non-consolidated) PDF
4/10
Mitsubishi Pharma to Withdraw from US Plasma Fractionation Business as US Subsidiary Transfers Operations
1/8
Sale of Selective Antithrombin Agent Novastan Injection Commences in China

News Release

  • News Release
  • Topics
  • Contact Us
  • Terms Of Use
  • Privacy Policy

Top of Page

© Mitsubishi Tanabe Pharma Corporation.